Close menu




August 30th, 2022 | 13:40 CEST

A look at how growth stocks are doing: NEL, Pathfinder Ventures, Deutsche Bank

  • Growth
  • Camping
  • Investments
Photo credits: pixabay.com

Now that the Fed has made it unmistakably clear that fighting inflation is a top priority, investors are asking what this means for their portfolios. Although popular opinion does not see much prospect for growth stocks in times of rising interest rates, it is worth looking at the details. What matters, in the end, is how robust business models are. Then financing solutions can also be found for growth stocks.

time to read: 3 minutes | Author: Nico Popp
ISIN: NEL ASA NK-_20 | NO0010081235 , PATHFINDER VENTURES INC | CA70323P1071 , DEUTSCHE BANK AG NA O.N. | DE0005140008

Table of contents:


    Joe Bleackley, CEO, Pathfinder Ventures Inc.
    "[...] In addition to campsite fees, Pathfinder Ventures has put itself in a position to offer all of these sought-after camping solutions. The only thing they don't sell is the RV itself. [...]" Joe Bleackley, CEO, Pathfinder Ventures Inc.

    Full interview

     

    NEL: Hydrogen on top

    The Norwegian hydrogen giant NEL has published some positive news in recent months. New record orders and the growing interest of large industrial companies in the hydrogen sector give hope that the NEL share will move forward again. For some weeks now, however, the share price has been moving sideways rather than upwards. The situation looks better for suppliers of fuel cells. Plug Power, for example, has entered into a cooperation agreement with Amazon, and the retail giant is even buying shares in the growth company. A crisis of growth stocks does not look like that!

    Nevertheless, it is worth taking a closer look at the business models. While suppliers of hydrogen mobility are currently on the verge of their products passing the practical test, innovative companies around hydrogen production are increasingly receiving competition from established industrial stocks. NEL is a stock that has potential, but its business model is not unique. Investors should be aware of this.

    Pathfinder Ventures: Campground investment niche

    Also a growth stock, but in an entirely different space, is Pathfinder Ventures. The Company is entering an area where primarily large real estate investors have been active up to now: Pathfinder operates and invests in campsites. The Company has previously operated in Canada, with a focus on British Columbia. The Canadian district north of the US state of Washington impresses with dreamlike nature and a comparatively dense population. Cities such as Vancouver, Kamloops and Kelowna are home to millions of people. In times of rising prices and travel restrictions, these people are increasingly looking for recreation nearby. That is where Pathfinder Ventures comes in with its three sites. All parks have excellent modern infrastructure and thus appeal particularly to families.

    In the medium term, Pathfinder intends to roll out its strategy on an even larger scale and has announced acquisitions. The market for campgrounds in Canada and also the USA is extremely fragmented. In many cases, owners have been managing individual parks themselves for decades. Pathfinder Ventures has the expertise to identify promising parks and has the experience of efficiently investing in infrastructure on the ground. True to its motto, "By campers for campers", Pathfinder has become a brand with charisma. Some campground operators may prefer to sell to Pathfinder in the future rather than to other investors who often see campgrounds as "cheap building land" and close parks rather than continue to operate them. Pathfinder Ventures is a down-to-earth growth stock with a clear mission. Those who see a perspective in camping and trust the Company's expertise around campgrounds may want to take a closer look at the stock.

    Deutsche Bank: Are growth companies more than fig leaves?

    When it comes to financing growth, banks also play a significant role - at least in theory. In practice, financial institutions are very skeptical when it comes to providing capital to founders. Especially when business models are innovative, banks lack a reference. As a result, startups rush to the capital market or serve venture capital investors to advance their ideas. For banks, this often leaves innovative opportunities untapped. In recent years, Deutsche Bank has opened up to growth companies and, among others, supports the bus company FlixBus and the company tonies, which offers a playback device for audio games and music for children. So far, however, such cooperations have not paid off on the prices of bank shares. Even when it became known last year that Commerzbank must have made a good cut with fintech investments, this left the share prices cold. The bottom line for investors: If you want growth in your portfolio, you have to invest in growth stocks yourself.


    Although interest rates are rising, the opportunities for innovative business models remain great. Firstly, interest rates are still low, and secondly, the cake is being distributed around future technologies such as hydrogen - anyone who does not invest now will probably be left out in the cold. But there are also prospects for traditional business models, such as the campsite operator Pathfinder Ventures. The Company also considers bank financing possible for acquisitions - unlike high-tech, Pathfinder's figures can be easily understood by any loan officer. The next few months will show how the Company can implement its plans.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Stefan Feulner on October 4th, 2022 | 11:59 CEST

    RWE, Pathfinder Ventures, United Internet - Panic as an opportunity

    • Camping
    • Investments

    Last week, the crash prophets crawled out of their caves and outdid themselves with forecasts reaching the Corona lows at around 8,000 points in the leading German DAX index. Without a doubt, the general conditions for a sustained stock rally are moderate with the escalation of the Ukraine situation and concerns about further interest rate hikes. Nevertheless, there are attractive entry opportunities at the current level, which could pay off in cash in the long term.

    Read

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read